Akihiro Tsuda

1.0k citations
41 papers · 662 indexed · h-index 17
Topics
Gout, Hyperuricemia, Uric Acid (8 papers)Chronic Kidney Disease and Diabetes (7 papers)Parathyroid Disorders and Treatments (6 papers)
Partner nations
Japan

In The Last Decade

Akihiro Tsuda

39 papers receiving 649 citations

Peers

Akihiro Tsuda
Comparison fields: 5 of 80
  • Nephrology 329
  • Endocrinology, Diabetes and Metabolism 120
  • Physiology 120
  • Surgery 101
  • Pathology and Forensic Medicine 96
Replace Hwee‐Yeong Ng with:
Hwee‐Yeong Ng Taiwan
Krystyna Widecka Poland
Lingjuan Zhu China
José A.M. Carvalho Brazil
Yintao Chen China
Stephen Fava Malta
Delian Zhang China
Ahmet Karabulut Türkiye
Leendert H. Oterdoom Netherlands
Ayumi Sugawara Japan
Akihiro Tsuda relative to Hwee‐Yeong Ng Taiwan Hwee‐Yeong Ng's profile →
Citations per field
00.5×1.6×
Hwee‐Yeong Ng · 1×
Citations per year

Countries citing papers authored by Akihiro Tsuda

Since Specialization
Citations

This map shows the geographic impact of Akihiro Tsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Tsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Tsuda more than expected).

Fields of papers citing papers by Akihiro Tsuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Tsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Tsuda. The network helps show where Akihiro Tsuda may publish in the future.

Co-authorship network of co-authors of Akihiro Tsuda

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Tsuda. A scholar is included among the top collaborators of Akihiro Tsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Tsuda. Akihiro Tsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 14
4 8
5 19
6 8
7 24
8 3
9 3
10 1
11 5
12 93
13 25
14 22
15 20
16 15
17 4
18 35
19 16
20 37

About Akihiro Tsuda

Akihiro Tsuda is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Hematology, having authored 41 papers that have together received 662 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (8 papers), Chronic Kidney Disease and Diabetes (7 papers) and Parathyroid Disorders and Treatments (6 papers). The work is most often cited by research in Nephrology (329 citations), Endocrinology, Diabetes and Metabolism (120 citations) and Pathology and Forensic Medicine (96 citations). Akihiro Tsuda has collaborated with scholars based in Japan. Frequent co-authors include Katsuhito Mori, Shinya Nakatani, Masaaki Inaba, Masanori Emoto, Eiji Ishimura, Hideki Uedono, Yasuo Imanishi, Shinsuke Yamada, Tatsuya Nakatani and Junji Uchida. Their work appears in journals such as PLoS ONE, Diabetes Care and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026